EFFECT OF P-2-PURINOCEPTOR ANTAGONISTS ON GLUTAMATERGIC TRANSMISSION IN THE RAT HIPPOCAMPUS

被引:52
|
作者
MOTIN, L [1 ]
BENNETT, MR [1 ]
机构
[1] UNIV SYDNEY,DEPT PHYSIOL,NEUROBIOL LAB,SYDNEY,NSW 2006,AUSTRALIA
关键词
P-2-PURINOCEPTORS; PATCH-CLAMP; HIPPOCAMPAL CELLS; SURAMIN; REACTIVE BLUE 2; PPADS;
D O I
10.1111/j.1476-5381.1995.tb15036.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 A study has been made of the effects of P-2-purinoceptor antagonists on the evoked excitatory postsynaptic currents (e.p.s.cs) generated in CA1 pyramidal cells on stimulation of Schaffer collaterals and in CA3 pyramidal cells on stimulation of messy fibres. The effects of these antagonists on currents generated in the cells on application of glutamate has also been determined. 2 Suramin blocked the evoked e.p.s.cs with an 50% inhibition (ID50) Of 62 +/- 8 mu M (mean +/- s.e. mean, n=17), spontaneous miniature e.p.s.cs and the currents induced by application of 100 mu M glutamate with an ID50 = 121 +/- 36 mu M (n=15) in all the cells studied. 3 Reactive Blue 2 (RE-2) in a concentration of 200 mu M decreased the e.p.s.cs by 80 +/- 10% (n=6) and the glutamate-activated currents by 83 +/- 3% (n=6). 4 Pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) in the concentration-range of 40-50 mu M decreased the amplitude of the e.p.s.cs in 12 out of 13 cells studied. PPADS at 200 mu M reduced the amplitude of the e.p.s.cs by 60 +/- 10% (n=3). PPADS did not affect the glutamate-induced currents in 4 cells and produced potentiation of the current amplitude by 60 +/- 10% in 4 other cells. 5 These results suggest that both presynaptic and postsynaptic P-2-purinoceptors in the hippocampus can modulate the release and action of endogenous glutamate.
引用
收藏
页码:1276 / 1280
页数:5
相关论文
共 50 条
  • [31] ANALYSIS OF P-2-PURINOCEPTOR SUBTYPES ON THE SMOOTH-MUSCLE AND ENDOTHELIUM OF RABBIT CORONARY-ARTERY
    CORR, L
    BURNSTOCK, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (05) : 709 - 715
  • [32] The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus
    Cheng, Qing
    Yakel, Jerrel L.
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (04) : 439 - 444
  • [33] Further evidence for allosteric interactions of purinoceptor antagonists with the P2X(4) purinoceptor
    Michel, AD
    Lundstrom, K
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P126 - P126
  • [34] Hydrolysis of P-2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase
    Picher, M
    Sevigny, J
    DOrleansJuste, P
    Beaudoin, AR
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (11) : 1453 - 1460
  • [35] P-2-PURINOCEPTOR ACTIVATION STIMULATES PHOSPHOINOSITIDE HYDROLYSIS AND INHIBITS ACCUMULATION OF CAMP IN CULTURED VENTRICULAR MYOCYTES
    YAMADA, M
    HAMAMORI, Y
    AKITA, H
    YOKOYAMA, M
    CIRCULATION RESEARCH, 1992, 70 (03) : 477 - 485
  • [36] PHILANTHOTOXINS BLOCK GLUTAMATERGIC TRANSMISSION IN RAT HIPPOCAMPUS .2. INHIBITION OF SYNAPTIC TRANSMISSION IN THE CA1 REGION
    SCHLUTER, NCM
    PIEK, T
    DASILVA, FHL
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1992, 101 (01): : 41 - 47
  • [37] Inhibition of releasable neuronal nucleotidases by P2-purinoceptor antagonists
    Mihaylova-Todorova, ST
    Todorov, LD
    Khoyi, M
    Westfall, DP
    FASEB JOURNAL, 2001, 15 (04): : A224 - A224
  • [38] EVIDENCE FOR THE PRESENCE OF BOTH PREJUNCTIONAL AND POSTJUNCTIONAL P-2-PURINOCEPTOR SUBTYPES IN HUMAN ISOLATED URINARY-BLADDER
    PALEA, S
    PIETRA, C
    TRIST, DG
    ARTIBANI, W
    CALPISTA, A
    CORSI, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) : 35 - 40
  • [39] P-2-PURINOCEPTOR AGONISTS INCREASE CAMP FORMATION IN MDCK CELLS BY INDOMETHACIN-SENSITIVE AND INSENSITIVE PATHWAYS
    RUMP, LC
    POST, SR
    JACOBSON, JP
    INSEL, PA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 810 - 810
  • [40] INHIBITION OF ECTOATPASE AND CA-ATPASE IN RAT VAS-DEFERENS BY P-2 PURINOCEPTOR ANTAGONISTS
    KHAKH, BS
    MICHEL, AD
    HUMPHREY, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 : P2 - P2